Vertex Pharmaceuticals (NASDAQ: VRTX)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Vertex Pharmaceuticals Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
These companies come from very different industries, but each has businesses that investors may find compelling.
This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024
This rare disease company is on a roll.
2 Top Healthcare Stocks Defying the Bear Market
These companies are building out their revenue and profit streams, and the proof is in the pudding.
2 Best Healthcare Stocks to Buy Right Now
The healthcare industry is an explosive space full of promising, profitable companies.
Vertex Pharmaceuticals: Buy at the High?
Vertex shares have been flying high in recent times.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Great healthcare businesses are out there and their stocks are ripe for the picking.
2 No-Brainer Growth Stocks to Buy Right Now
These businesses are thriving and raking in profits.
3 Red-Hot Growth Stocks That Are Still Cheap Buys
It's not too late to invest in these great businesses.
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2023.
Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2023.
Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2022.
Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.